Sub-Ischial Socket for Transfemoral Amputation and Lower Mobility

February 26, 2024 updated by: Stefania Fatone, University of Washington

Evaluation of the Northwestern University Subischial Socket for Persons With Transfemoral Amputation and Lower Mobility Levels

The objective of this trial is to assess use and benefits of the subischial socket for persons with transfemoral amputation and lower mobility levels. Specifically, the investigators will evaluate whether the subischial socket improves comfort, socket wear time, mobility, participation, quality of life and satisfaction with device than the standard-of-care ischial containment socket.

Study Overview

Detailed Description

Prosthetic sockets that are currently used by persons with above-the-knee amputation (AKA) fit intimately with the thigh and pelvis, limiting hip motion and causing discomfort. Socket comfort while standing and sitting is of great importance to persons with lower limb amputation. Yet discomfort while sitting has been reported in 44% of persons with AKA. In those with AKA who are more sedentary, clinical observation indicates that socket discomfort in sitting results in less prosthesis wear time and less mobility with the prosthesis. Based on these observations, the investigators propose that improving socket comfort in persons with AKA who have lower mobility will increase the time spent wearing the socket, which will in turn increase mobility, and in turn again improve satisfaction with the prosthesis and overall quality-of-life. A new prosthetic socket design, the sub-ischial socket, which eliminates contact with the pelvis, has been developed with the intent of improving comfort and hip motion in people with AKA. In particular, sitting comfort has been highlighted as an advantage of this new socket design by early users. Therefore, the objective of this project is to assess use and benefits of the sub-ischial socket for persons with AKA and lower mobility levels. The investigators will evaluate whether the sub-ischial socket is more comfortable, improves prosthesis wear time, mobility, participation in society, satisfaction with device, skin-related quality-of-life, and health-related quality of life compared to the current standard-of-care socket design in persons with AKA and lower mobility levels. If a participant is eligible and enrolled into this study, participation would last about 10 months and would involve up to 8 in-person visits (for individuals receiving a new sub-ischial socket). Individuals receiving a new sub-ischial socket will also be asked to wear a step counter and temperature sensor and complete 11 remote survey assessments spread over the 10-month period of the study. Data will also be collected from a reference group of participants with transfemoral amputation and lower mobility levels who will not receive a sub-ischial socket. These participants will be assessed while wearing their clinically-provided, standard-of-care ischial containment socket. These participants will complete 8 remote survey assessments over a 10-month period.

Study Type

Interventional

Enrollment (Estimated)

115

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Rana Salem, MA
  • Phone Number: 206-221-2414
  • Email: rsalem@uw.edu

Study Contact Backup

  • Name: Stefania Fatone, PhD
  • Phone Number: 206-685-7918
  • Email: sfaton@uw.edu

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55417
        • Recruiting
        • Minneapolis VA Health Care System
        • Contact:
    • Texas
      • Houston, Texas, United States, 78758
        • Recruiting
        • Hanger Institute for Clinical Research and Education
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Speak and read English;
  2. Provision of signed and dated informed consent form;
  3. Stated willingness to comply with all study procedures and availability for the duration of the study;
  4. All sexes and genders age 18 years and older;
  5. Have a unilateral transfemoral or knee disarticulation amputation and have used a prosthesis for 1 year or more;
  6. Be classified by their prosthetist as being a Medicare Functional Classification Level of K2 (limited community ambulator);
  7. Have never worn a sub-ischial socket;
  8. Current IC socket and prosthesis must be well fitting and maintained; current socket must have pelvic weightbearing and/or containment;
  9. Participant has no plans to change the knee or foot in the next 10 months;
  10. Willingness to adhere to the monitoring and new socket regimen;
  11. Have sufficient upper limb function to don liner and change sensors;
  12. Access to necessary resources for participating in the study (i.e., computer, smartphone, internet access, telephone):
  13. Be a Veteran (VA site only).

Exclusion Criteria (intervention group only):

  1. Have a femoral length <5 inches;
  2. Have a known silicone allergy;
  3. Are unable to don or tolerate wearing a compressive liner;
  4. Loss of metatarsal heads on contralateral limb;
  5. Active malignancy;
  6. Pregnancy;
  7. Polytrauma that affects functional ability beyond that of a unilateral transfemoral amputation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
Participants will be assessed for 12 weeks in their usual ischial containment socket before receiving a subischial socket to be worn and assessed for 24 weeks.
A custom-made prosthetic socket for transfemoral amputation that consists of proximal trimlines that do not interact with the pelvis.
No Intervention: Reference Group
Participants will be assessed for 40 weeks in their usual ischial containment socket. No intervention will be provided.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Socket Comfort Score (SCS)
Time Frame: Change from week 12 to week 24 compared between Intervention and Reference Groups.
Single item self-report measure to rate average socket comfort on an 11-point scale where 0 represents the most uncomfortable socket fit participant can imagine and 10 represents the most comfortable socket fit participant can imagine. Participants will rate their socket comfort in general, and while sitting, standing, and walking.
Change from week 12 to week 24 compared between Intervention and Reference Groups.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Temperature sensor
Time Frame: Intervention group only: Baseline period weeks 0-12; Intervention period weeks 0-24.
Temperature sensor measures and records temperature and time at variable intervals. The temperature sensor will be retrofit to the liner worn with the usual socket and installed in the liner worn with the sub-ischial socket so that wear time can be monitored for the entire study duration.
Intervention group only: Baseline period weeks 0-12; Intervention period weeks 0-24.
Step counter
Time Frame: Intervention group only: Baseline period weeks 0-4; Intervention period weeks 0-4 and 20-24.
A step counter activity monitor is an ankle-worn, microprocessor-controlled, two-dimensional accelerometer that measures step counts and step rates per unit time.
Intervention group only: Baseline period weeks 0-4; Intervention period weeks 0-4 and 20-24.
Falls
Time Frame: All participants: Baseline period weeks 0, 4, 8, 12; Intervention group: Intervention period weeks 0, 4, 8, 12, 16, 20, 24; Reference group: Monitoring period weeks 4, 12, 20, 24.
Falls will be self-reported by participants at each assessment time point. Participants will be asked if they have fallen in the past 4 weeks. If the participant indicates that they have fallen, they will ask how many times they have fallen in the past 4 weeks, whether the fall resulted in an injury, and if applicable, type of injury and whether they sought medical attention for the fall.
All participants: Baseline period weeks 0, 4, 8, 12; Intervention group: Intervention period weeks 0, 4, 8, 12, 16, 20, 24; Reference group: Monitoring period weeks 4, 12, 20, 24.
Activities-specific Balance Confidence (ABC) Scale
Time Frame: All participants: Baseline period weeks 0, 4, 8, 12; Intervention group: Intervention period weeks 4, 8, 12, 16, 20, 24; Reference group: Monitoring period weeks 4, 12, 20, 24.
16-item self-report measure where individuals rate their balance confidence in performing various activities without losing balance or experiencing a sensation of unsteadiness. Items are rated on a scale from 0-4, with 0 representing no balance confidence and 4 representing complete balance confidence. Total scores are created by averaging across the 16 items, with total scores ranging from 0 to 4. The higher the total score, the better the balance confidence.
All participants: Baseline period weeks 0, 4, 8, 12; Intervention group: Intervention period weeks 4, 8, 12, 16, 20, 24; Reference group: Monitoring period weeks 4, 12, 20, 24.
Prosthesis Evaluation Questionnaire (PEQ) Residual Limb Health
Time Frame: All participants: Baseline period weeks 0, 4, 8, 12; Intervention group: Intervention period weeks 0, 4, 8, 12, 16, 20, 24; Reference group: Monitoring period weeks 4, 12, 20, 24.
6-item self-report measure where individuals rate severity of residual limb issues such as rashes, sores, or sweating. Items are rated on a scale from 0-10, with 0 indicating that a residual limb problem/issue is very bothersome and 10 indicating that it is not at all bothersome. Total score is created by averaging across the 6 items, with possible scores ranging from 0-10. The higher the total score, the better the residual limb health.
All participants: Baseline period weeks 0, 4, 8, 12; Intervention group: Intervention period weeks 0, 4, 8, 12, 16, 20, 24; Reference group: Monitoring period weeks 4, 12, 20, 24.
Roland-Morris Disability Questionnaire (RMDQ)
Time Frame: All participants: Baseline period weeks 0, 4, 8, 12; Intervention group: Intervention period weeks 0, 4, 8, 12, 16, 20, 24; Reference group: Monitoring period weeks 4, 12, 20, 24.
24-item self-report questionnaire used to determine the level of disability due to low-back pain. Items are rated as yes or no, with yes indicating that the responder endorses the statement as describing them today. Total score possible is 0-24, with scores indicative of the number of statements endorsed. The higher the total score, the more disabling the low-back pain.
All participants: Baseline period weeks 0, 4, 8, 12; Intervention group: Intervention period weeks 0, 4, 8, 12, 16, 20, 24; Reference group: Monitoring period weeks 4, 12, 20, 24.
Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health-10
Time Frame: All participants: Baseline period weeks 0, 12; Intervention/Monitoring period weeks 4, 12, 24.
10-item self-report measure used to assess general domains of health and functioning including overall physical health, mental health, social health, pain, fatigue, and overall perceived quality of life. Nine items are rated on a scale of 1-5 with a variety of response options (e.g., poor to excellent or always to never). The lower the score the worse health across all 9 items. One item is rated on a scale of 0-10 with 0 being no pain and 10 being worst imaginable pain. Four of the 10 items are combined to create a global mental health raw score that ranges from 4 to 20. Similarity, four items are combined to create a global physical health raw score that also ranges from 4 to 20. Raw scores are converted to T-scores and higher scores indicate better mental or physical health. The remaining two items are used individually in analyses and are not included in the overall physical or mental health scores.
All participants: Baseline period weeks 0, 12; Intervention/Monitoring period weeks 4, 12, 24.
Orthotic and Prosthetic Users' Survey Satisfaction with Device (OPUS-SwD)
Time Frame: All participants: Baseline period weeks 0, 12; Intervention/Monitoring period weeks 4, 12, 24.
9-item self-report measure to assess satisfaction with device in persons who use prostheses. Items are rated 1-5 with 1 indicating strongly disagree and 5 indicating strongly agree. Total score possible is 9-45. The higher the score the better the satisfaction with device. The raw scores are converted to Rasch Measures.
All participants: Baseline period weeks 0, 12; Intervention/Monitoring period weeks 4, 12, 24.
Prosthesis Limb Users Survey-Mobility (PLUS-M)
Time Frame: All participants: Baseline period weeks 0, 4, 8, 12; Intervention group: Intervention period weeks 4, 8, 12, 16, 20, 24; Reference group: Monitoring period weeks 4, 12, 20, 24.
12-item self-report instrument for measuring mobility of adults with lower limb amputation (i.e., the ability to move intentionally and independently from one place to another). Items are rated on a scale from 1-5, with 1 indicating participants are unable to do the task and 5 indicating that participants can do it without any difficulty. Total raw scores range from 12-60. Raw scores are converted to a T-score using a lookup table, and final scores range from 20.3 to 67.7 on the T-score metric. The higher the total score the better the mobility.
All participants: Baseline period weeks 0, 4, 8, 12; Intervention group: Intervention period weeks 4, 8, 12, 16, 20, 24; Reference group: Monitoring period weeks 4, 12, 20, 24.
Patient-Reported Outcomes Measurement Information System (PROMIS) Ability to Participate in Social Roles
Time Frame: All participants: Baseline period weeks 0, 12; Intervention/Monitoring period weeks 4, 12, 24.
4-item self-report measure to assess satisfaction with one's usual social roles in life's situations and activities. These roles may exist in marital relationships, parental responsibilities, work responsibilities and social activities. Items are rated on a scale of 1-5 with 1 indicating participants always experienced the issue and 5 being never. Total raw score possible is 4-20. The raw score is converted to a t-score that ranges from 27.5 to 64.2 on the T-score metric. A higher score indicates better ability to participate in social roles.
All participants: Baseline period weeks 0, 12; Intervention/Monitoring period weeks 4, 12, 24.
Patient-Reported Outcomes Measurement Information System (PROMIS) Depression
Time Frame: All participants: Baseline period weeks 0, 12; Intervention/Monitoring period weeks 4, 12, 24.
4-item self-report measure used to assess depression. Items are rated on a scale of 1-5 with 1 indicating participants have never experienced the issue and 5 being always. Total raw scores range from 4-20 and are converted to T-scores using a lookup table. Final T-scores range from 41.0 to 79.4. A lower score indicates less depressive symptoms.
All participants: Baseline period weeks 0, 12; Intervention/Monitoring period weeks 4, 12, 24.
Charlson Comorbidity Index (CCI)
Time Frame: All participants: Baseline period week 0; Intervention/Monitoring period weeks 4, 24.
11-item self-report measure that assesses the presence of common health conditions. Items are rated as yes or no, with yes indicating participants have the health condition. Total score possible is 0-11. The higher the score, the more comorbid conditions the individual has.
All participants: Baseline period week 0; Intervention/Monitoring period weeks 4, 24.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Amputee Mobility Predictor with Prosthesis (AMP-Pro)
Time Frame: Intervention group only: Baseline period week 0; Intervention period weeks 0, 20.
21-item in-person performance-based measure that assesses mobility potential of people with a lower limb prosthesis that evaluates transfers, sitting and standing balance, and gait skills. Items are variably scored, and item scores can range from 0-1 to 0-5. Total score possible is 0-47. The higher the score, the higher the mobility category.
Intervention group only: Baseline period week 0; Intervention period weeks 0, 20.
International Society for Prosthetics and Orthotics (ISPO) Minimum Data Set for lower-limb prosthesis users involved Research Studies
Time Frame: Intervention group: Baseline period week 0; Intervention period week 0. Reference Group: Baseline period week 0.
Descriptive information about the participant and prosthesis will include all the variables recommended by ISPO in their data set for lower-limb prosthesis users involved in research studies. These include participant characteristics (eg, age, weight, amputation level, reason for amputation, time since amputation, prosthetic experience, residual limb shape categorization, residual limb sensation qualitative assessment, lower extremity joint range of motion, manual muscle testing of lower limb strength, previous history of gait training with a therapist, and assistive device use). The list also includes prosthesis characteristics: structural design of prosthesis, socket type, suspension, prosthetic foot, ankle, shank and knee components, and type of residual limb socks.
Intervention group: Baseline period week 0; Intervention period week 0. Reference Group: Baseline period week 0.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stefania Fatone, PhD, University of Washington

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2023

Primary Completion (Estimated)

August 31, 2025

Study Completion (Estimated)

August 31, 2025

Study Registration Dates

First Submitted

December 12, 2022

First Submitted That Met QC Criteria

December 20, 2022

First Posted (Actual)

December 23, 2022

Study Record Updates

Last Update Posted (Actual)

February 28, 2024

Last Update Submitted That Met QC Criteria

February 26, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00015284
  • CDMRP-E03034.1a (Other Grant/Funding Number: Congressionally Directed Medical Research Programs)
  • CDMRP-E03034.1b (Other Grant/Funding Number: Congressionally Directed Medical Research Programs)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data generated by this research will be made available to the research community and to the public via University of Washington ResearchWorks digital repository of scholarly work. Prior to sharing, data will be de-identified and redacted to reduce the risk of participant identification. Final research data will include the factual material necessary to document and support research findings such as the outcome measure results and participant characteristics upon which any accepted publications are based, it may include both raw data and derived variables. Documentation will also be provided regarding the procedures used to collect and analyze the data.

IPD Sharing Time Frame

Data will be shared no later than the acceptance for publication of the main findings from the final dataset.

IPD Sharing Access Criteria

ResearchWorks creates persistent URLs that will not change over time. A DOI can also be created. The URL or DOI will be included with all publications arising from this trial.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Transfemoral Amputation

Clinical Trials on Northwestern University Flexible Subischial Suction Socket (NU-FlexSIS)

3
Subscribe